Micelle controlled release of 5-fluorouracil: Follow the guideline for good polymer-drug compatibility

Colloids and Surfaces A: Physicochemical and Engineering Aspects

Volumn 457, Issue 1, 2014, Pages 116-124

  Yuan, Ming ^a   Xiao, Yan ^a   Le, Vanminh ^b   Wei, Chao ^a   Fu, Yutong ^a   Liu, Jianwen ^b   Lang, Meidong ^a  

^a East China University of Science and Technology   (China)

^b EAST CHINA UNIVERSITY OF SCIENCE AND TECHNOLOGY   (China)

Author keywords

5 Fluorouracil; Drug delivery system; Flory Huggins interaction parameter; Poly(e open carprolactone); Polymer drug compatibility

Indexed keywords

CELL DEATH; DRUG DELIVERY; DRUG INTERACTIONS; ESTERIFICATION; ESTERS; HYDROPHILICITY; MICELLES; MOTION PICTURE EXPERTS GROUP STANDARDS; ORGANIC ACIDS; POLYETHYLENE GLYCOLS; POLYMERS;

5-FLUOROURACIL; DRUG DELIVERY SYSTEM; FLORY-HUGGINS INTERACTION PARAMETER; POLY(E{OPEN}-CARPROLACTONE); POLYMER-DRUG COMPATIBILITY;

LOADING;

COPOLYMER; FLUOROURACIL; MONOMETHOXY POLY(ETHYLENE GLYCOL) POLY[GAMMA(CARBAMIC ACID BENZYL ESTER)EPSILON CAPROLACTONE]; POLYCAPROLACTONE; UNCLASSIFIED DRUG;

APOPTOSIS; ARTICLE; CHEMICAL STRUCTURE; CONTROLLED RELEASE FORMULATION; CONTROLLED STUDY; CRITICAL MICELLE CONCENTRATION; CYTOTOXICITY; DRUG DELIVERY SYSTEM; DRUG SOLUBILITY; FLUORESCENCE SPECTROSCOPY; HCT116 CELL LINE; HYDROPHILICITY; HYDROPHOBICITY; IN VITRO STUDY; MICELLE; MISCIBILITY; PARTICLE SIZE; POLYMERIZATION; PRIORITY JOURNAL; SYNTHESIS; ZETA POTENTIAL;

EID: 84902479921     PISSN: 09277757     EISSN: 18734359     Source Type: Journal    
DOI: 10.1016/j.colsurfa.2014.04.062     Document Type: Article

References (55)

1. Rider B.J. 5 Fluorouracil. xPharm: The Comprehensive Pharmacology Reference 2007, 1-5. Elsevier, New York. S.J. Enna, D.B. Bylund (Eds.).
2. Longley D.B., Harkin D.P., Johnston P.G. 5-fluorouracil: mechanisms of action and clinical strategies. Nat. Rev. Cancer 2003, 3:330-338.
3. Tanaka F., Fukuse T., Wada H., Fukushima M. The history, mechanism and clinical use of oral 5-fluorouracil derivative chemotherapeutic agents. Curr. Pharm. Biotechnol. 2000, 1:137-164.
4. You F., Aoki K., Ito Y., Nakashima S. AKT plays a pivotal role in the acquisition of resistance to 5-fluorouracil in human squamous carcinoma cells. Mol. Med. Rep. 2009, 2:609-613.
5. Li X., Li H., Liu G., Deng Z., Wu S., Li P., Xu Z., Xu H., Chu P.K. Magnetite-loaded fluorine-containing polymeric micelles for magnetic resonance imaging and drug delivery. Biomaterials 2012, 33:3013-3024.
6. Rajan M., Raj V., Al-Arfaj A.A., Murugan A.M. Hyaluronidase enzyme core-5-fluorouracil-loaded chitosan-PEG-gelatin polymer nanocomposites as targeted and controlled drug delivery vehicles. Int. J. Pharm. 2013, 453:514-522.
7. Zhu K., Ye T., Liu J., Peng Z., Xu S., Lei J., Deng H., Li B. Nanogels fabricated by lysozyme and sodium carboxymethyl cellulose for 5-fluorouracil controlled release. Int. J. Pharm. 2013, 441:721-727.
8. 2 G4 dendrimer and 5-fluorouracil in aqueous solution. Int. J. Pharm. 2012, 428:178-182.
9. Seo H.W., Kim D.Y., Kwon D.Y., Kwon J.S., Jin L.M., Lee B., Kim J.H., Min B.H., Kim M.S. Injectable intratumoral hydrogel as 5-fluorouracil drug depot. Biomaterials 2013, 34:2748-2757.
10. Yang Y., Zhou Z., He S., Fan T., Jin Y., Zhu X., Chen C., Zhang Z.-r., Huang Y. Treatment of prostate carcinoma with (Galectin-3)-targeted HPMA copolymer-(G3-C12)-5-fluorouracil conjugates. Biomaterials 2012, 33:2260-2271.
11. Yan X., Zhu P., Li J. Self-assembly and application of diphenylalanine-based nanostructures. Chem. Soc. Rev. 2010, 39:1877-1890.
12. Li H., Jia Y., Wang A., Cui W., Ma H., Feng X., Li J. Self-assembly of hierarchical nanostructures from dopamine and polyoxometalate for oral drug delivery. Chem. Eur. J. 2014, 20:499-504.
13. Wang L., Jiang T., Lin J. Self-assembly of graft copolymers in backbone-selective solvents: a route toward stable hierarchical vesicles. RSC Adv. 2013, 3:19481-19491.
14. Chen L., Chen T., Fang W., Wen Y., Lin S., Lin J., Cai C. Synthesis and pH-responsive "schizophrenic" aggregation of a linear-dendron-like polyampholyte based on oppositely charged polypeptides. Biomacromolecules 2013, 14:4320-4330.
15. Zhang Y., Li J., Lang M., Tang X., Li L., Shen X. Folate-functionalized nanoparticles for controlled 5-fluorouracil delivery. J. Colloid Interface Sci. 2011, 354:202-209.
16. Krzyzaniak J.F., Yalkowsky S.H. Lysis of human red blood cells 3: effect of contact time on surfactant-induced hemolysis. PDA J. Pharm. Sci. Technol. 1998, 52:66-69.
17. Abdelwahed W., Degobert G., Fessi H. A pilot study of freeze drying of poly(e{open}-caprolactone) nanocapsules stabilized by poly(vinyl alcohol): formulation and process optimization. Int. J. Pharm. 2006, 309:178-188.
18. Ataman-Önal Y., Munier S., Ganée A., Terrat C., Durand P.-Y., Battail N., Martinon F., Le Grand R., Charles M.-H., Delair T., Verrier B. Surfactant-free anionic PLA nanoparticles coated with HIV-1 p24 protein induced enhanced cellular and humoral immune responses in various animal models. J. Control. Release 2006, 112:175-185.
19. Thomas A.M., Kapanen A.I., Hare J.I., Ramsay E., Edwards K., Karlsson G., Bally M.B. Development of a liposomal nanoparticle formulation of 5-fluorouracil for parenteral administration: formulation design, pharmacokinetics and efficacy. J. Control. Release 2011, 150:212-219.
20. Shuai X., Ai H., Nasongkla N., Kim S., Gao J. Micellar carriers based on block copolymers of poly(e{open}-caprolactone) and poly(ethylene glycol) for doxorubicin delivery. J. Control. Release 2004, 98:415-426.
21. Gou M., Zheng X., Men K., Zhang J., Wang B., Lv L., Wang X., Zhao Y., Luo F., Chen L., Zhao X., Wei Y., Qian Z. Self-assembled hydrophobic honokiol loaded MPEG-PCL diblock copolymer micelles. Pharm. Res. 2009, 26:2164-2173.
22. Park E.K., Kim S.Y., Lee S.B., Lee Y.M. Folate-conjugated methoxy poly(ethylene glycol)/poly(e{open}-caprolactone) amphiphilic block copolymeric micelles for tumor-targeted drug delivery. J. Control. Release 2005, 109:158-168.
23. Park E.K., Lee S.B., Lee Y.M. Preparation and characterization of methoxy poly(ethylene glycol)/poly(e{open}-caprolactone) amphiphilic block copolymeric nanospheres for tumor-specific folate-mediated targeting of anticancer drugs. Biomaterials 2005, 26:1053-1061.
24. Hoffman A.S. The origins and evolution of "controlled" drug delivery systems. J. Control. Release 2008, 132:153-163.
25. Uhrich K.E., Cannizzaro S.M., Langer R.S., Shakesheff K.M. Polymeric systems for controlled drug release. Chem. Rev. 1999, 99:3181-3198.
26. Knop K., Hoogenboom R., Fischer D., Schubert U.S. Poly(ethylene glycol) in drug delivery: pros and cons as well as potential alternatives. Angew. Chem. Int. Edit. 2010, 49:6288-6308.
27. Hao J., Rainbolt E.A., Washington K., Biewer M.C., Stefan M.C. Synthesis of functionalized poly(caprolactone)s and their application as micellar drug delivery systems. Curr. Org. Chem. 2013, 17:930-942.
28. Xiao Y., Yuan M., Zhang J., Yan J., Lang M. Functional poly(e{open}-caprolactone) based materials: preparation, self-assembly and application in drug delivery. Curr. Top. Med. Chem. 2014, 14:781-818.
29. Lamprecht A., Yamamoto H., Takeuchi H., Kawashima Y. Observations in simultaneous microencapsulation of 5-fluorouracil and leucovorin for combined pH-dependent release. Eur. J. Pharm. Biopharm. 2005, 59:367-371.
30. Arias J.L., López-Viota M., Delgado Á.V., Ruiz M.A. Iron/ethylcellulose (core/shell) nanoplatform loaded with 5-fluorouracil for cancer targeting. Colloids Surf. B. Biointerfaces 2010, 77:111-116.
31. Li P., Wang Y., Peng Z., She F., Kong L. Development of chitosan nanoparticles as drug delivery systems for 5-fluorouracil and leucovorin blends. Carbohydr. Polym. 2011, 85:698-704.
32. Chang L., Deng L., Wang W., Lv Z., Hu F., Dong A., Zhang J. Poly(ethyleneglycol)-b-poly(e{open}-caprolactone-co-γ-hydroxyl-e{open}-caprolactone) bearing pendant hydroxyl groups as nanocarriers for doxorubicin delivery. Biomacromolecules 2012, 13:3301-3310.
33. Kim S.H., Tan J.P.K., Nederberg F., Fukushima K., Colson J., Yang C., Nelson A., Yang Y.-Y., Hedrick J.L. Hydrogen bonding-enhanced micelle assemblies for drug delivery. Biomaterials 2010, 31:8063-8071.
34. Yan J., Ye Z., Chen M., Liu Z., Xiao Y., Zhang Y., Zhou Y., Tan W., Lang M. Fine tuning micellar core-forming block of poly(ethylene glycol)-block-poly(e{open}-caprolactone) amphiphilic copolymers based on chemical modification for the solubilization and delivery of doxorubicin. Biomacromolecules 2011, 12:2562-2572.
35. Suksiriworapong J., Sripha K., Kreuter J.r., Junyaprasert V.B. Investigation of polymer and nanoparticle properties with nicotinic acid and p-aminobenzoic acid grafted on poly(e{open}-caprolactone)-poly(ethylene glycol)-poly(e{open}-caprolactone) via click chemistry. Bioconjugate Chem. 2011, 22:582-594.
36. Zhang Y., Liu J., Fu Y., Tan K., Ye Z., Lang M. Self-assembly of polyion complex nanocarriers from ammonium glycyrrhizinate and monomethoxy poly(ethylene glycol)-b-poly(γ-amino-e{open}-caprolactone). J. Mater. Chem. B 2013, 1:1614-1621.
37. Thakral S., Thakral N.K. Prediction of drug-polymer miscibility through the use of solubility parameter based Flory-Huggins interaction parameter and the experimental validation: PEG as model polymer. J. Pharm. Sci. 2013, 102:2254-2263.
38. Danquah M., Fujiwara T., Mahato R.I. Self-assembling methoxypoly(ethylene glycol)-b-poly(carbonate-co-l-lactide) block copolymers for drug delivery. Biomaterials 2010, 31:2358-2370.
39. Yan J., Zhang Y., Xiao Y., Zhang Y., Lang M. Novel poly(e{open}-caprolactone)s bearing amino groups: synthesis, characterization and biotinylation. React. Funct. Polym. 2010, 70:400-407.
40. Yan J., Ye Z., Luo H., Chen M., Zhou Y., Tan W., Xiao Y., Zhang Y., Lang M. Synthesis, characterization, fluorescence labeling and cellular internalization of novel amine-functionalized poly(ethylene glycol)-block-poly(e{open}-caprolactone) amphiphilic block copolymers. Polym. Chem. 2011, 2:1331-1340.
41. Mahmud A., Patel S., Molavi O., Choi P., Samuel J., Lavasanifar A. Self-associating poly(ethylene oxide)-b-poly(α-cholesteryl carboxylate-e{open}-caprolactone) block copolymer for the solubilization of STAT-3 inhibitor cucurbitacin I. Biomacromolecules 2009, 10:471-478.
42. 1H-NMR, and fluorescence studies of interaction between 5-fluorouracil and polyglycerol dendrimers. J. Phys. Chem. B 2012, 116:12263-12267.
43. Rejinold N.S., Muthunarayanan M., Chennazhi K.P., Nair S.V., Jayakumar R. 5-Fluorouracil loaded fibrinogen nanoparticles for cancer drug delivery applications. Int. J. Biol. Macromol. 2011, 48:98-105.
44. Rejinold N.S., Nair A., Sabitha M., Chennazhi K.P., Tamura H., Nair S.V., Jayakumar R. Synthesis, characterization and in vitro cytocompatibility studies of chitin nanogels for biomedical applications. Carbohydr. Polym. 2012, 87:943-949.
45. Liu J., Zhang Y., Yan J., Lang M. Synthesis and solution properties of pH responsive methoxy poly(ethylene glycol)-b-poly(γ-amino-e{open}-caprolactone). J. Mater. Chem. 2011, 21:6677-6682.
46. Liu G., Dong C.-M. Photoresponsive poly(S-(o-nitrobenzyl)-l-cysteine)-b-PEO from a l-cysteine N-carboxyanhydride monomer: synthesis, self-assembly, and phototriggered drug release. Biomacromolecules 2012, 13:1573-1583.
47. Zhang W., Li Y., Liu L., Sun Q., Shuai X., Zhu W., Chen Y. Amphiphilic toothbrushlike copolymers based on poly(ethylene glycol) and poly(e{open}-caprolactone) as drug carriers with enhanced properties. Biomacromolecules 2010, 11:1331-1338.
48. Bian Q., Xiao Y., Lang M. Thermoresponsive biotinylated star amphiphilic block copolymer: synthesis, self-assembly, and specific target recognition. Polymer 2012, 53:1684-1693.
49. Lee R.-S., Hung C.-B. Synthesis and characterization of amphiphilic block copolymers from poly(ethylene glycol)methyl ether and 4-methyl-e{open}-caprolactone or 4-phenyl-e{open}-caprolactone. Polymer 2007, 48:2605-2612.
50. Mountrichas G., Pispas S. Synthesis and pH responsive self-assembly of new double hydrophilic block copolymers. Macromolecules 2006, 39:4767-4774.
51. Davis M.E. Nanoparticle therapeutics: an emerging treatment modality for cancer. Nat. Rev. Drug Discov. 2008, 7:771-782.
52. Moghimi S.M., Hunter A.C., Murray J.C. Long-circulating and target-specific nanoparticles: theory to practice. Pharmacol. Rev. 2001, 53:283-318.
53. Zahr A.S., Davis C.A., Pishko M.V. Macrophage uptake of core-shell nanoparticles surface modified with poly(ethylene glycol). Langmuir 2006, 22:8178-8185.
54. Zhang Y., Li J., Du Z., Lang M. Synthesis and pH-responsive assembly of methoxy poly(ethylene glycol)-b-poly(e{open}-caprolactone) with pendant carboxyl groups. J. Polym. Sci. Pol. Chem. 2014, 52:188-199.
55. Lo C.-L., Lin K.-M., Hsiue G.-H. Preparation and characterization of intelligent core-shell nanoparticles based on poly(d,l-lactide)-g-poly(N-isopropyl acrylamide-co-methacrylic acid). J. Control. Release 2005, 104:477-488.